Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, is recognizing a critical milestone ...
Today, the National Comprehensive Cancer Network® (NCCN®)?an alliance of leading cancer centers?published a new resource to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback